Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-034468)

Filing Details

Accession Number:: 0001209191-14-034468
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2014-05-16 10:56:24
Reporting Period:: 2014-05-16

Filing Date:: 2014-05-16
Accepted Time:: 2014-05-16 10:56:24
Original Submission Date:: 2014-05-16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
786947	Acura Pharmaceuticals Inc	ACUR	Pharmaceutical Preparations (2834)	110853640

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1056695	A Peter Clemens	C/O Acura Pharmaceuticals, Inc. 616 N. North Court, Suite 120 Palatine IL 60067	Senior Vp And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-05-16	3,000	$1.21	275,918	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3,605	Indirect	By Son